Actively Recruiting
Assessment of ICU and Non-ICU Survivors: Creating a COVID-19 Survivorship Database
Led by NYU Langone Health · Updated on 2025-10-30
1500
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting a study to better understand the degree and severity of lung and heart injury caused by COVID-19, as well as the short- and long-term effects of the infection. This study focuses on patients who have recently been diagnosed with COVID-19, including those who were treated in the ICU, hospitalized, or not hospitalized. It also aims to assess mental health and quality of life after COVID-19 infection. Participants will undergo various assessments including chest imaging, MRI, echocardiograms, spirometry, and blood tests to gather information about heart and lung structure and function. Questionnaires will be used to evaluate mental health indicators such as depression and anxiety. The study includes both COVID-19 patients and a control group without a history of COVID-19. During the study, participants will be monitored for up to 12 months. Researchers will measure inflammatory markers and collect questionnaire data on breathlessness and caregiver burden. The study involves assessments of lung and heart function, mental health, and quality of life over time to provide a comprehensive understanding of COVID-19 survivorship and its impacts.
CONDITIONS
Brief Title
COVID-19 Survivorship Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Tested positive for SARS-CoV-2 and discharged from ICU, or
- Tested positive for SARS-CoV-2 and discharged from hospital, or
- Tested positive for SARS-CoV-2 but was not hospitalized
- Aged 18 years or older
- Competent and willing to sign informed consent and follow the study protocol
- Control group: No history or active symptoms of COVID-19
- Control group aged 18 years or older
- Control group competent and willing to sign informed consent and follow the study protocol
You will not qualify if you...
- Unable to sign consent
- Pregnant or trying to become pregnant
- Unable to comply with protocol requirements (e.g., removing metal before MRI)
- Contraindications to MRI such as non-MRI-safe pacemakers, metal implants, shrapnel, or tattoos near the eye
- Persistent COVID-19 symptoms (may be re-screened later)
- Control exclusions: pacemaker, poorly controlled diabetes, restrictive lung disease, heart failure, Parkinson's disease, hypertension, or autonomic neuropathy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 12 months
Participants undergo chest imaging, MRI, Echo, Spirometry, and blood tests to assess the severity of cardiopulmonary injury and other health indicators.
Multiple assessments over 12 months
Duration - Up to 12 months
Participants complete questionnaires and are monitored for mental health, quality of life, and ongoing health outcomes related to COVID-19.
Regular follow-up visits during the 12 months
Trial Site Locations
Total: 1 location
1
NYU Langone Health
New York, New York, United States, 10016
Actively Recruiting
Research Team
A
Ashley Witzl
D
Daniel Walsh
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here